Get detailed information on Ranitidine, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it. The updated prescription ...

Since 2019, there have been 15 peer-reviewed epidemiological studies on the effects of ranitidine use on humans which reflect the scientific consensus that there is no consistent or reliable ...

Zantac was a popular medication used to treat heartburn, acid reflux, and related gastrointestinal issues. However, in 2019, the U.S. Food and Drug Administration (FDA) discovered that Zantac and ...

In its latest statement, GSK reiterated its position that after “16 epidemiological studies looking at human data regarding the use of ranitidine, the scientific consensus is that there is no ...

Nary a day goes by that the plaintiffs’ bar is not busily at work initiating a new mass tort action. Some cases expand on ...

Finally, Valisure raises the specter of opioid’s “arch-villain” Purdue: “GSK engaged in a massive, nationwide marketing campaign to convince doctors—and patients, for the first time ever—to use ...

GSK has also reached an agreement to pay $70 million to resolve the Zantac Qui Tam suit previously filed by Valisure. The arrangement is awaiting final approval from the Department of Justice.

British pharmaceutical company GSK on Wednesday said it swung into a net loss in the third quarter after settling lawsuits in the United States surrounding its Zantac heartburn drug. GSK suffered ...

UK pharmaceutical giant GSK says it will pay as much as $2.2bn (£1.68bn) to settle thousands of cases in US courts over claims that a discontinued version of its heartburn drug Zantac caused cancer.

The pharmaceutical giant reported a drop in profit due to charges related to the Zantac lawsuits but has reaffirmed guidance ...

When possible, MeSH terms were used and expanded upon. Truncation was employed for a maximum number of results. In addition, the references for each medication with a reported false-positive UDS ...